Coronary Angioplasty/Stents for Cardiac Allograft Vasculopathy Does Not Alter Outcome for Heart Transplant Patients with ISHLT CAV2 or CAV3 Disease

被引：0
|
作者：
Patel, J. [1 ]
Azarbal, B. [1 ]
Kittleson, M. [1 ]
Kawano, M. [1 ]
Goldstein, Z. [1 ]
Rafiei, M. [1 ]
Moradzadeh, A. [1 ]
Czer, L. [1 ]
Kass, R. [1 ]
Kobashigawa, J. [1 ]
机构：
[1] Cedars Sinai Heart Inst, Los Angeles, CA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2011年 / 30卷 / 04期
关键词：
D O I：
10.1016/j.healun.2011.01.018
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11
引用
收藏
页码：S11 / S12
页数：2
相关论文
共 16 条
  • [1] Does Aspirin Reduce the Rate of Early Cardiac Allograft Vasculopathy (CAV) Following Heart Transplant?
    Bloom, J. E.
    Iglesias, C. Pereira Kessler
    Moskovitch, J.
    Letchford, D.
    Kotlyar, E.
    Offen, S.
    Keogh, A.
    Jabbour, A.
    Hayward, C.
    Kaye, D. M.
    Muthiah, K.
    Macdonald, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S282 - S282
  • [2] Value of the First Biopsy for Predicting Cardiac Allograft Vasculopathy (CAV) in Heart Transplant Patients
    Labarrere, C. A.
    Woods, J. R.
    Hardin, J. W.
    Campana, G. L.
    Ortiz, M. A.
    Jaeger, B. R.
    Reichart, B.
    Baldridge, L. A.
    Bonnin, J. M.
    Currin, A.
    Cosgrove, S. K.
    Kirlin, P. C.
    Pitts, D. E.
    O'Donnell, J. A.
    Hormuth, D. A.
    Wozniak, T. C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S171 - S172
  • [3] First-Year Brain Natriuretic Peptide (BNP) as a Biomarker after Heart Transplant To Predict Severity of Cardiac Allograft Vasculopathy (CAV) as Per the New ISHLT CAV Scale
    Patel, J.
    Kittleson, M.
    Shiozaki, R.
    Rafiei, M.
    Stern, L.
    Azarbal, B.
    Czer, L.
    Esmailian, F.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S122 - S122
  • [4] Carbohydrate Metabolism Disorders in Relation to Cardiac Allograft Vasculopathy (CAV) Intensification in Heart Transplant Patients According to the Grading Scheme Developed by the International Society for Heart and Lung Transplantation (ISHLT)
    Zielinska, Katarzyna
    Kukulski, Leszek
    Wrobel, Marta
    Przybylowski, Piotr
    Rokicka, Dominika
    Strojek, Krzysztof
    ANNALS OF TRANSPLANTATION, 2022, 27
  • [5] Cardiac Allograft Vasculopathy (CAV) in Children: An 18 Year Pediatric Heart Transplant Study (PHTS) Analysis in 3120 Patients
    Kindel, S. J.
    Chin, C.
    Law, Y.
    Burch, M. M.
    Kirklin, J. K.
    Naftel, D. C.
    Carboni, M. P.
    Arens, A.
    Atz, A. M.
    Dryer, W. J.
    Pahl, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S53 - S54
  • [6] First Angioplasty Does Not Appear To Alter Outcome in Heart Transplant Patients with Newly Diagnosed Transplant Coronary Artery Disease
    Kittleson, M.
    Patel, J.
    Azarbal, B.
    Moriguchi, J.
    Kawano, M.
    Davis, S.
    Hage, A.
    Ardehali, A.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S124 - S124
  • [7] The Doppler Derived Myocardial Performance Index (MPI) May Detect Patients with Coronary Allograft Vasculopathy (CAV) in Pediatric Heart Transplant Recipients
    Schubert, S.
    Lehmkuhl, H. B.
    Yegitbasi, M.
    Huebler, M.
    Hiemann, N.
    Hetzer, R.
    Berger, F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S172 - S172
  • [8] Value of the First Post-Transplant Biopsy for Predicting Long-Term Cardiac Allograft Vasculopathy (CAV) and Graft Failure in Heart Transplant Patients
    Labarrere, Carlos A.
    Woods, John R.
    Hardin, James W.
    Campana, Gonzalo L.
    Ortiz, Miguel A.
    Jaeger, Beate R.
    Baldridge, Lee Ann
    Pitts, Douglas E.
    Kirlin, Philip C.
    PLOS ONE, 2012, 7 (04):
  • [9] FIRST-YEAR BRAIN NATRIURETIC PEPTIDE (BNP) AS A BIOMARKER AFTER HEART TRANSPLANT FOR POOR OUTCOME AND PREDICTION OF THE SEVERITY OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV)
    Shiozaki, R.
    Rafiei, M.
    Stern, L. K.
    Hamilton, M.
    Kobashigawa, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 172 - 173
  • [10] Clinical Risk-Prediction of a Novel Thrombosis/Activation (TA) Score to Prognosticate Long-Term Cardiac Allograft Vasculopathy (CAV) in Heart Transplant Patients
    Labarrere, C. A.
    Woods, J. R.
    Hardin, J. W.
    Campana, G. L.
    Ortiz, M. A.
    Jaeger, B. R.
    Reichart, B.
    Baldridge, L. A.
    Bonnin, J. M.
    Currin, A.
    Cosgrove, S. K.
    Kirlin, P. C.
    O'Donnell, J. A.
    Hormuth, D. A.
    Wozniak, T. C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S36 - S37
12